Neutralizing human antibodies against CD55 and CD59 targeted to lymphoma cells in vivo potentiate the therapeutic effect of Rituximab

✍ Scribed by P. Macor; E. Piovan; S. Zorzet; C. Tripodo; R. Marzari; A. Amadori; F. Tedesco

• Book ID: 116756084
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 77 KB
• Volume: 44
• Category: Article
• ISSN: 0161-5890
• DOI: 10.1016/j.molimm.2006.07.152